Eight Advisory supported Sofina as part of its investment in OrganOx
Eight Advisory provided financial due diligence services to Sofina as part of its investment in OrganOx, a leading organ medical technology company. Sofina participated in a $142 million primary and secondary equity financing round that will accelerate growth opportunities for the company’s metra® platform technology, which is approved for use in transplants in the US, Europe, Canada and Australia
Eight Advisory team members supporting on this transaction:
- Financial due diligence: Jonathan Broom (Partner), Niall O’Dea (Partner), Anurang Hariharan (Senior Manager), Elliot Heim (Manager)
